Schering and Novartis tweak respiratory drug collaboration
In a joint statement today, Schering-Plough and Novartis announced changes to the collaboration agreements regarding both companies' respiratory portfolios.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.